Portable platform for the assessment of microvascular health in COVID-19 patients at the intensive care

VASCOVID was one of the thirteen projects selected by the European Commission special call for addressing the COVID-19 pandemic. Its objective was to deploy and mature a portable, non-invasive and real-time health monitoring platform for this purpose.

The VASCOVID platform combines two bio-photonics technologies, time-resolved near-infrared spectroscopy (TR-NIRS) and diffuse correlation spectroscopy (DCS), and is the fruit of long-term collaboration between core project partners in previous research projects. The goal was to design the platform to meet the needs of a typical ICU dealing with COVID-19 and other patients requiring ventilation, as well as to leverage large-scale testing of new treatment procedures and therapies, aimed to address microvascular impairment and to reduce extubation failure on ICU patients.

PIONIRS contributed to the project with its TR-NIRS technology, providing state-of-art hardware for the VASCOVID platform, and helping other partner in the overall integration and characterization of the final system.

The project is successfully ended on May 31st 2023, 

check out results and achievements on the official VASCOVID project website:

VASCOVID project partners:

EIC - LOGO 2021

This project has received funding from the

European Union’s Horizon 2020 research and innovation programme 

under grant agreement No 101016087.